Ji-Won Kim
Vermögen: 38 627 $ am 30.06.2026
Vermögen: 38 627 $ am 30.06.2026
Ji-Won Kim currently works at Aju IB Investment Co., Ltd. (Private Equity), as Chief Executive Officer, AJU IB Investment Co., Ltd., as Chief Executive Officer & Director from 1999, and SL VaxiGen, Inc., as Director.
Mr. Kim received his undergraduate degree from Yonsei University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.06.2026 | 12.416 ( 0,01 % ) | 38 627 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AJU IB INVESTMENT CO., LTD. | Vorstandsvorsitzender | 01.01.1999 |
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Vorstandsvorsitzender | - |
SL VaxiGen, Inc.
SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures vaccine therapeutics | Direktor/Vorstandsmitglied | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
Yonsei University
Yonsei University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aju IB Investment Co., Ltd. (Private Equity)
Aju IB Investment Co., Ltd. (Private Equity) Investment ManagersFinance Aju IB is a long-term investor focused on high technology Korean companies with significant growth potential. Aju IB's investment criteria include management's capability, ethics and transparency, potential market leadership or ability to control the market, technological barriers to entry, significant market size, profitability and maturity. They also take into consideration portfolio diversification. | Finance |
AJU IB Investment Co., Ltd.
AJU IB Investment Co., Ltd. Investment ManagersFinance Invests in venture and new technology businesses | Finance |
SL VaxiGen, Inc.
SL VaxiGen, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures vaccine therapeutics | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen